Published in Biotech Business Week, January 3rd, 2005
PCA involves the engineering of probes of molecular interactions, with widespread applications for drug discovery and pharmacological profiling in living cells. Professor Stephen W. Michnick, of the University of Montreal, invented PCA and has applied the technology to a wide range of reporters for high-throughput and high-content applications. PCA is applicable to any and all drug targets, drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.